Imperial College London (ICL) is a science-based university with an international reputation for excellence in teaching and research. Consistently rated among the world's best universities (No. 06 in the world by QS ranking), Imperial is dedicated to developing the next generation of researchers, scientists, and academics through collaboration across the world. ICL offers world-class education and research in science, engineering, medicine and business, with particular regard to their application in industry, commerce and healthcare. Imperial was fully committed to involvement in FP7 and Horizon 2020, as demonstrated by its participation in over 670 FP7 and 430 Horizon 2020 projects.
Imperial will develop integrated quantitative nucleic acid microsensors (i.e., TriSilix) for rapid Point-of-Need (PoN) detection of diseases affecting fish (WP6). ICL will tailor TriSilix to detect several fish pathogens using samples extracted from the gills, skin and blood, towards individual and multiplexed detection. ICL will also design a customised disposable cartridge containing the TriSilix chip and the reagents for operation in the field. Imperial will also support WP1 and WP8
